Introduction
============

Patients with primary acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) may develop secondary abdominal pathologies associated with increased intra-abdominal pressure (IAP) and, vice versa, primary abdominal problems can be associated with intra-abdominal hypertension (IAH) and secondary ALI/ARDS \[[@B1]-[@B3]\]. Correct bedside measurement of IAP in daily clinical practice is important. The IAP value is influenced by physiological (eg, body weight, body position, abdominal muscle activity), non-physiological (eg, surgical pneumoperitoneum) and multiple pathological situations (eg, abdominal trauma, pancreatitis, liver transplantation) \[[@B2],[@B4]\]. A persistent increase of IAP can produce multiple adverse effects, involving both intra-abdominal (eg, kidney, bowel) and extra-abdominal (eg, respiratory, cardiovascular) organ systems. Clinical symptoms can occur when the IAP exceeds 12 mmHg \[[@B5]\]. The management of abdominal compartment syndrome (ACS) consists of optimising medical treatment; however, if that fails, surgical decompression should be considered, because it can be a life-saving procedure. Medical management of ALI/ARDS patients with ACS can consist of sedation (sometimes with the use of neuromuscular blockers), intubation and mechanical ventilation with positive end-expiratory pressure (PEEP), sometimes at high levels \[[@B5]\]. Several studies focused on the effects of IAH on other organ systems, especially the respiratory system \[[@B1],[@B5]\]. The World Society of the Abdominal Compartment Syndrome (WSACS) \[[@B6]\] has published consensus definitions and guidelines for the diagnosis, management, prevention and treatment of IAH and ACS \[[@B5]\]. Although methods used to measure IAP are now well defined, few studies \[[@B7]-[@B9]\] have investigated the influence of the adjustment of respiratory parameters on IAP values. We hypothesised that an increase in the PEEP level can lead to an increase in IAP values in ALI/ARDS patients. The aim of this physiological pilot study was to evaluate the impact of different PEEP levels on IAP values.

Materials and methods
=====================

Over a six-month period (January to June 2006) all consecutive patients admitted to the ICU of Saint-Eloi University hospital in Montpellier, France, with abdominal diseases (peritonitis, pancreatitis, liver transplantation and abdominal trauma) that had IAP monitoring and that were under mechanical ventilation for ALI/ARDS (partial pressure of arterial oxygen (PaO~2~)/fraction of inspired oxygen (FiO~2~) \< 300 mmHg) were included. The ventilation modality used was volume controlled and the tidal volume selected for each patient was unchanged throughout the whole period of the study. All patients were sedated to obtain a Richmond Agitation Sedation Scale (RASS) at -5 or -4 without muscle relaxant. Demographic data were also recorded.

The protocol was approved by the local ethics committee and informed consent was provided by patients or next of kin. Bedside measurements of IAP were performed by transduction of pressure from an indwelling bladder catheter after priming with sterile saline (50 ml), according to the modified Kron technique \[[@B10]\]. IAP was always measured in the complete supine position at end-expiration with the transducer zeroed at the midaxillary line (at the level of the iliac crest), in stable conditions (absence of abdominal muscle contractions). Together with IAP, hemodynamic and respiratory parameters were measured during a PEEP trial with three consecutive PEEP settings in the same order (0, 6 and 12 cmH~2~O). These measurements were obtained after a stabilisation period of five minutes after change in PEEP setting.

Results are expressed as mean ± standard deviation. Patients with an IAP below 12 mmHg (low-IAP group) were compared with those with an IAP of 12 mmHg or more (high-IAP group) at zero end-expiratory pressure (ZEEP). The appropriate analyses of variance were applied for all comparisons between the different PEEP levels. A *P*\< 0.05 was considered to be significant.

Results
=======

During the study period, 287 patients were admitted to our ICU. Fourteen women and sixteen men were enrolled in the study. For the whole group, age was 55 ± 17 years, weight was 70 ± 17 kg, height was 167 ± 15 cm, body mass index was 25.2 ± 5.6 kg/m^2^, simplified acute physiology score II was 44 ± 14 and PaO~2~/FIO~2~ratio was 192 ± 53 mmHg. Main causes of admission were peritonitis (*n*= 19), acute pancreatitis (*n*= 5), haemoperitoneum (*n*= 4) and ileus (*n*= 2).

Main haemodynamic and respiratory parameters in the low-IAP group (*n*= 15) and the high-IAP group (*n*= 15) are listed in Table [1](#T1){ref-type="table"}. No significant difference was observed between the low-IAP and high-IAP group with regard to demographic data. The effects of PEEP on IAP are represented in Figure [1](#F1){ref-type="fig"}. Increase in PEEP involved a significant rise in IAP (ZEEP vs PEEP 12 cmH~2~O, *P*\< 0.05). The overall mean increase in IAP (ΔIAP) was 3.5 ± 1.7 mmHg. This increase was less pronounced when basic IAP (at ZEEP) was less than 12 mmHg (low-IAP group) whereas it was significantly higher at higher baseline levels of IAP (high-IAP group).

###### 

Haemodynamic and respiratory parameters at the three PEEP levels

  **PEEP level (cmH**~**2**~**O)**                                0           6           12
  ------------------------------------ -------------------------- ----------- ----------- -----------
  Heart rate, beats/min                Total (*n*= 30)            87 ± 16     83 ± 22     90 ± 19
                                       High IAP group (*n*= 15)   95 ± 17     88 ± 27     97 ± 19
                                       Low IAP group (*n*= 15)    77 ± 10     78 ± 11     80 ± 13
  Mean arterial pressure, mmHg         Total (*n*= 30)            89 ± 14     88 ± 14     85 ± 12
                                       High IAP group (*n*= 15)   90 ± 15     88 ± 15     84 ± 12
                                       Low IAP group (*n*= 15)    89 ± 12     88 ± 13     87 ± 13
  Abdominal perfusion pressure, mmHg   Total (*n*= 30)            77 ± 13     74 ± 14     70 ± 12\*
                                       High IAP group (*n*= 15)   74 ± 15     70 ± 15     64 ± 11\*
                                       Low IAP group (*n*= 15)    79 ± 11     78 ± 12     76 ± 11
  Central venous pressure, mmHg        Total (*n*= 30)            11 ± 4      12 ± 4      14 ± 5\*
                                       High IAP group (*n*= 15)   11 ± 4      13 ± 4      14 ± 4\*
                                       Low IAP group (*n*= 15)    10 ± 5      11 ± 5      13 ± 5\*
  Cardiac output, L/min                Total (*n*= 13)            6.0 ± 2.0   5.8 ± 1.7   5.8 ± 1.8
                                       High IAP group (*n*= 8)    6.7 ± 2.0   6.4 ± 1.7   6.4 ± 1.8
                                       Low IAP group (*n*= 5)     5.0 ± 1.6   4.9 ± 1.4   4.7 ± 1.3
  Respiratory rate, breaths/min        Total (*n*= 30)            17 ± 4      17 ± 4      17 ± 4
                                       High IAP group (*n*= 15)   18 ± 4      18 ± 4      18 ± 4
                                       Low IAP group (*n*= 15)    16 ± 3      16 ± 3      16 ± 3
                                                                                          
  Tidal volume, ml                     Total (*n*= 30)            634 ± 142   633 ± 145   629 ± 146
                                       High IAP group (*n*= 15)   639 ± 178   640 ± 180   634 ± 183
                                       Low IAP group (*n*= 15)    628 ± 84    624 ± 88    623 ± 89
  Plateau airway pressure, cmH~2~O     Total (*n*= 30)            20 ± 5      24 ± 4      29 ± 5\*
                                       High IAP group (*n*= 15)   22 ± 5      25 ± 3      31 ± 3\*
                                       Low IAP group (*n*= 15)    18 ± 5      22 ± 4      26 ± 5\*
  Dynamic compliance, ml/cmH~2~O       Total (*n*= 30)            41 ± 14     44 ± 15     47 ± 17\*
                                       High IAP group (*n*= 15)   42 ± 17     44 ± 18     46 ± 20\*
                                       Low IAP group (*n*= 15)    40 ± 11     44 ± 12     48 ± 12\*

Values are expressed as mean ± standard deviation.

Abdominal perfusion pressure was calculated as: mean arterial pressure minus IAP.

\**P*\< 0.05 PEEP0 *vs*PEEP12.

IAP, intra-abdominal pressure; PEEP, positive end-expiratory pressure.

![**Effects of PEEP on IAP measure in all patients (*n*= 30), low IAP group (*n*= 15) and high IAP group (*n*= 15)**. \**P*\< 0.05 PEEP0 *vs*PEEP12. \*\**P*\< 0.01 PEEP0 *vs*PEEP12. IAP, intra-abdominal pressure; PEEP, positive end-expiratory pressure.](cc9193-1){#F1}

In the 13 patients in whom cardiac output was measured, an increase in PEEP from 0 to 12 cmH~2~O did not significantly change cardiac output, nor in the 8 of 15 patients of the high-IAP group (Table [1](#T1){ref-type="table"}).

The observed effects were similar in both ALI (*n*= 17) and ARDS (*n*= 13) patients.

Discussion
==========

The main findings of the study are that: moderate PEEP levels can lead to increases in IAP due to transmission of intrathoracic pressure to the abdomen; and this effect should be considered in interpreting IAP measurements in selected patients with ALI/ARDS who are on high levels of PEEP and vice versa setting a lower level of PEEP may have a beneficial effect on IAP.

The IAP is considered to be an important physiological parameter in critically ill patients, and IAP monitoring becomes more often a common practice in the ICU \[[@B1],[@B5],[@B10]\]. The impact of increased IAP on respiratory function in the critically ill has been well studied \[[@B2],[@B4]\]. Mechanical ventilation with high PEEP has been shown to decrease splanchnic perfusion \[[@B1],[@B5]\]. Reduction of splanchnic blood flow is limited at PEEP levels below 10 cmH~2~O, but it is more pronounced at PEEP levels of 15 to 20 cmH~2~O. A significant decrease in abdominal perfusion pressure at 12 cmH~2~O of PEEP was observed and this effect was more pronounced in the high-IAP group (Table [1](#T1){ref-type="table"}), confirming previous results \[[@B11]\].

The effects of PEEP on IAP values were such that they would increase the IAH grading. A recent classification by WSACS graded IAH as follow: grade I = IAP 12 to 15 mmHg; grade II = IAP 16 to 20 mmHg; grade III = IAP 21 to 25 mmHg; grade IV = IAP above 25 mmHg \[[@B5]\]. ACS is defined as a sustained IAP of more than 20 mmHg that is associated with new organ failure. Therefore, using the thresholds of the WSACS, the application of 12 cmH~2~O PEEP could increase the IAH grading by one grade. For example, in our study, one patient with grade III IAH was classified as having ACS after PEEP 12 cmH~2~O.

In the literature (Table [2](#T2){ref-type="table"}) there is some controversy about the effect of mechanical ventilation and the use of PEEP on IAP. The heterogeneity of the observed differences in reported results between the different studies (Table [2](#T2){ref-type="table"}) may be explained in part by the differences in the patient populations. Sussman and colleagues \[[@B8]\] was the first to look at the effects of PEEP on IAP and in their experiment increasing PEEP to 15 cmH~2~O did not affect the IAP. However, in the study by Sussman and colleagues \[[@B8]\], 10 of the 15 studied patients had just had laparotomy. However, others \[[@B7],[@B9]\] have found a mild increase in IAP in patients with a baseline IAP below 12 mmHg when increasing PEEP to 15 cmH~2~O (Table [2](#T2){ref-type="table"}). Further, in patients with a baseline IAP above 12 mmHg the effect of PEEP seems to be more pronounced \[[@B9]\] as we found in the present study.

###### 

Effect of PEEP on IAP in human studies

                            **Sussman and colleagues**\[[@B8]\]   **Gattinoni and colleagues**\[[@B7]\]   **Torquato and colleagues**\[[@B9]\]   Present study
  ------------------------- ------------------------------------- --------------------------------------- -------------------------------------- ---------------
  Publication year          1991                                  1998                                    2009                                   2009
  Patients (n)              15                                    21                                      30                                     30
  IAP zero reference        SP                                    SP                                      SP                                     MA
  IAP volume (ml)           50                                    100                                     60                                     50
  PEEP baseline (cmH~2~O)   0                                     0                                       0                                      0
  PEEP set (cmH~2~O)        15                                    15                                      10                                     12
  ΔPEEP (cmH~2~O)           15                                    15                                      10                                     12
  ΔPEEP (mmHg)              11                                    11                                      7.4                                    8.8
  IAP at baseline (mmHg)    10.8                                  10.6 ± 6                                8.7 ± 4.5                              11.7 ± 4.5
  IAP at PEEP (mmHg)        11.7                                  11.8 ± 6.3                              12.3 ± 9.6                             15.2 ± 5.8
  ΔIAP (mmHg)               0.9                                   1.4 ± 1.3                               3.6 ± 2.6                              3.5 ± 1.7

Continuous data are reported as mean ± standard deviation.

ΔPEEP = difference between the two extreme PEEP levels.

ΔIAP = IAP recorded at PEEP minus IAP at baseline.

IAP, intra-abdominal pressure; MA, midaxillary line; PEEP, positive end-expiratory pressure; SP, symphysis pubis.

We found that increasing PEEP from 0 to 12 cmH~2~O resulted in a significant decrease in abdominal perfusion pressure (mean arterial pressure minus IAP) in the high IAP compared with the low-IAP group. This may suggest a difference in preload between the two groups. However, we can only speculate on this. The final message is that application of PEEP may have a detrimental effect on abdominal perfusion pressure especially if the patient is already hypovolaemic and/or already has a high baseline IAP.

Two recent studies looked at the effect of head-of-bed positioning on IAP in critically ill intubated patients \[[@B12],[@B13]\]. The authors concluded that the potential contribution of body position in elevating IAP should be considered in patients with moderate to severe IAH or ACS. In the WSACS recommendations, IAP should always be measured in the full supine position. Acute respiratory failure, especially with elevated intrathoracic pressure and diminished abdominal wall compliance is recognised as a risk factor for IAH or ACS. Medical management of patients with IAH and ALI can lead to the decision of mechanical ventilation with PEEP (sometimes at high levels). In the above mentioned, it is difficult to ascertain the real IAP value and the impact on IAH management. Indeed, like increased PEEP, some other conditions such as prone or semi-recumbent positions add an artifactual pressure on IAP that is removed by returning to the reference supine position.

There are limitations to this study. First, the number of patients studied in each group was small. Second, only PEEP levels up to 12 cmH~2~O were studied. We can speculate that the effect of PEEP is dose related and a higher PEEP level (\>12 cmH~2~O) may further increase the IAP in critically ill patients. Third, the fact that preload was not well defined could have affected the results. Fourth, ideally pleural pressure should have been measured in order to quantify the respective effects of chest and lung mechanics on the thoracoabdominal transmission of PEEP to IAP. Finally, because the study was conducted before the publication of the consensus definitions a further limitation of the study was the fact that 50 ml of saline were instilled into the bladder.

Conclusions
===========

Our results suggest that a high PEEP level may be a risk factor for IAH in selected ALI/ARDS patients. Therefore, PEEP should be applied cautiously in IAH patients. The use of limited PEEP, set to counteract the effects of IAP at the level of the diaphragm may have beneficial effects. As suggested by several authors and the WSACS, standardised IAP measurement methods in mechanically ventilated patients, taking into account body position, zero reference, sedation and muscle paralysis and PEEP levels are needed.

Key messages
============

• Methods used to measure IAP are now well defined and some factors may influence the interpretation of IAP values.

• In ARDS patients, PEEP is a risk factor for IAH.

• PEEP should be applied cautiously in IAH patients and thus lowering PEEP to an appropriate level may have a beneficial effect on IAP.

• Standardised IAP measurement methods in mechanically ventilated patients, taking into account body position, zero reference, sedation and muscle paralysis and PEEP levels are needed.
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